Literature DB >> 31891663

Heme Oxygenase-1 Upregulation: A Novel Approach in the Treatment of Cardiovascular Disease.

Lars Bellner1, Nachum B Lebovics1, Rochelle Rubinstein1, Yosef D Buchen1, Emilia Sinatra1, Giuseppe Sinatra1, Nader G Abraham1,2, John A McClung2, Ellen A Thompson3.   

Abstract

Significance: Heme oxygenase (HO) plays a pivotal role in both vascular and metabolic functions and is involved in many physiological and pathophysiological processes in vascular endothelial cells (ECs) and adipocytes. Recent Advances: From the regulation of adipogenesis in adipose tissue to the adaptive response of vascular tissue in the ECs, HO plays a critical role in the capability of the vascular system to respond and adjust to insults in homeostasis. Recent studies show that HO-1 through regulation of adipocyte and adipose tissue functions ultimately aid not only in local but also in systemic maintenance of homeostasis. Critical Issues: Recent advances have revealed the existence of a cross talk between vascular ECs and adipocytes in adipose tissue. In the pathological state of obesity, this cross talk contributes to the condition's adverse chronic effects, and we propose that specific targeting of the HO-1 gene can restore signaling pathways and improve both vascular and adipose functions. Future Directions: A complete understanding of the role of HO-1 in regulation of cardiovascular homeostasis is important to comprehend the homeostatic regulation as well as in cardiovascular disease. Efforts are required to highlight the effects and the ability to target the HO-1 gene in models of obesity with an emphasis on the role of pericardial fat on cardiovascular health.

Entities:  

Keywords:  adipocytes; cardiovascular disease; heme oxygenase; obesity; oxidative stress

Mesh:

Substances:

Year:  2020        PMID: 31891663      PMCID: PMC7153645          DOI: 10.1089/ars.2019.7970

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  141 in total

Review 1.  VEGF in Signaling and Disease: Beyond Discovery and Development.

Authors:  Rajendra S Apte; Daniel S Chen; Napoleone Ferrara
Journal:  Cell       Date:  2019-03-07       Impact factor: 41.582

2.  Lentiviral-human heme oxygenase targeting endothelium improved vascular function in angiotensin II animal model of hypertension.

Authors:  Jian Cao; Komal Sodhi; Kazuyoshi Inoue; John Quilley; Rita Rezzani; Luigi Rodella; Luca Vanella; Lucrezia Germinario; David E Stec; Nader G Abraham; Attallah Kappas
Journal:  Hum Gene Ther       Date:  2011-01-27       Impact factor: 5.695

3.  Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle.

Authors:  Zoltan Arany; Huamei He; Jiandie Lin; Kirsten Hoyer; Christoph Handschin; Okan Toka; Ferhaan Ahmad; Takashi Matsui; Sherry Chin; Pei-Hsuan Wu; Igor I Rybkin; John M Shelton; Monia Manieri; Saverio Cinti; Frederick J Schoen; Rhonda Bassel-Duby; Anthony Rosenzweig; Joanne S Ingwall; Bruce M Spiegelman
Journal:  Cell Metab       Date:  2005-04       Impact factor: 27.287

Review 4.  Heme oxygenase and the kidney.

Authors:  Nathalie Hill-Kapturczak; Se-Ho Chang; Anupam Agarwal
Journal:  DNA Cell Biol       Date:  2002-04       Impact factor: 3.311

5.  Apolipoprotein A-I mimetic peptide L-4F prevents myocardial and coronary dysfunction in diabetic mice.

Authors:  C Vecoli; J Cao; D Neglia; K Inoue; K Sodhi; L Vanella; K K Gabrielson; D Bedja; N Paolocci; A L'abbate; N G Abraham
Journal:  J Cell Biochem       Date:  2011-09       Impact factor: 4.429

6.  Human biliverdin reductase is a leucine zipper-like DNA-binding protein and functions in transcriptional activation of heme oxygenase-1 by oxidative stress.

Authors:  Zulfiqar Ahmad; Mohammad Salim; Mahin D Maines
Journal:  J Biol Chem       Date:  2001-12-31       Impact factor: 5.157

Review 7.  Heme oxygenase: a target gene for anti-diabetic and obesity.

Authors:  N G Abraham; P L Tsenovoy; J McClung; G S Drummond
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

8.  Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes.

Authors:  Nader G Abraham; Rita Rezzani; Luigi Rodella; Adam Kruger; Derek Taller; Giovanni Li Volti; Alvin I Goodman; Attallah Kappas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-07-29       Impact factor: 4.733

9.  The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice.

Authors:  Stephen J Peterson; Dong Hyun Kim; Ming Li; Vincenzo Positano; Luca Vanella; Luigi F Rodella; Francesco Piccolomini; Nitin Puri; Amalia Gastaldelli; Claudia Kusmic; Antonio L'Abbate; Nader G Abraham
Journal:  J Lipid Res       Date:  2009-02-17       Impact factor: 5.922

10.  Apigetrin inhibits adipogenesis in 3T3-L1 cells by downregulating PPARγ and CEBP-α.

Authors:  Fatma Hadrich; Sami Sayadi
Journal:  Lipids Health Dis       Date:  2018-04-25       Impact factor: 3.876

View more
  7 in total

Review 1.  Heme-oxygenase and lipid mediators in obesity and associated cardiometabolic diseases: Therapeutic implications.

Authors:  John A McClung; Lior Levy; Victor Garcia; David E Stec; Stephen J Peterson; Nader G Abraham
Journal:  Pharmacol Ther       Date:  2021-09-06       Impact factor: 12.310

Review 2.  The Role of Polyphenol in Modulating Associated Genes in Diabetes-Induced Vascular Disorders.

Authors:  Nor Anizah Mohd Nor; Siti Balkis Budin; Satirah Zainalabidin; Juriyati Jalil; Syaifuzah Sapian; Fatin Farhana Jubaidi; Nur Najmi Mohamad Anuar
Journal:  Int J Mol Sci       Date:  2022-06-07       Impact factor: 6.208

3.  Protection Against Post-resuscitation Acute Kidney Injury by N-Acetylcysteine via Activation of the Nrf2/HO-1 Pathway.

Authors:  Shiwei Wang; Guoxiang Liu; Tianyuan Jia; Changsheng Wang; Xiaoye Lu; Lei Tian; Qian Yang; Changqing Zhu
Journal:  Front Med (Lausanne)       Date:  2022-05-17

Review 4.  OX-HDL: A Starring Role in Cardiorenal Syndrome and the Effects of Heme Oxygenase-1 Intervention.

Authors:  Stephen J Peterson; Abu Choudhary; Amardeep K Kalsi; Shuyang Zhao; Ragin Alex; Nader G Abraham
Journal:  Diagnostics (Basel)       Date:  2020-11-20

Review 5.  Vascular and Macrophage Heme Oxygenase-1 in Hypertension: A Mini-Review.

Authors:  Marta Martínez-Casales; Raquel Hernanz; María J Alonso
Journal:  Front Physiol       Date:  2021-02-26       Impact factor: 4.566

6.  Induction of Heme Oxygenase-1 Modifies the Systemic Immunity and Reduces Atherosclerotic Lesion Development in ApoE Deficient Mice.

Authors:  Leyi Yao; Yali Hao; Guanmei Wen; Qingzhong Xiao; Penglong Wu; Jinheng Wang; Jinbao Liu
Journal:  Front Pharmacol       Date:  2022-02-24       Impact factor: 5.810

Review 7.  Heme Oxygenase-1: An Anti-Inflammatory Effector in Cardiovascular, Lung, and Related Metabolic Disorders.

Authors:  Stefan W Ryter
Journal:  Antioxidants (Basel)       Date:  2022-03-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.